Medtrum Drug Delivery System with Graphical User Interface
Summary
The USPTO published patent application US20260091175A1 by Medtrum Technologies Inc. covering a drug delivery system with graphical user interface for insulin infusion and blood glucose monitoring. The system includes a detection device, infusion device, and control device with GUI displaying insulin infusion status and blood glucose information. Filing date was September 13, 2022.
What changed
Medtrum Technologies Inc. filed patent application US20260091175A1 for a drug delivery system integrating blood glucose detection and insulin infusion with a graphical user interface. The system comprises three components: a detection device for measuring blood glucose, an infusion device for delivering insulin, and a control device with GUI that displays insulin infusion status and blood glucose data in both graphical and textual formats. CPC classifications include A61M 5/1723, A61M 5/14244, and G16H 20/17.
This is a patent application publication with no compliance obligations or regulatory requirements. No action is required by regulated entities. Patent applications do not create binding obligations and are informational only for competitive intelligence purposes.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
DRUG DELIVERY SYSTEM WITH GRAPHICAL USER INTERFACE
Application US20260091175A1 Kind: A1 Apr 02, 2026
Assignee
MEDTRUM TECHNOLOGIES INC.
Inventors
Cuijun Yang
Abstract
The invention discloses a drug delivery system with graphical user interface comprises a detection device, for detecting the blood glucose level of the user; an infusion device, for infusing a drug into the user's body; and a control device, wirelessly communicated with the detection device and the infusion device, the control device controlling the drug delivery of the infusion device, and the control device provided with a graphical user interface, the graphical user interface comprising a main screen, the main screen comprising an insulin information display area and a blood glucose information display area, wherein the insulin information display area comprising insulin infusion status information, the graphical user interface displays the insulin infusion status information in a graphical and/or textual manner, to facilitate the user to intuitively know the insulin infusion status information and blood glucose information at that time.
CPC Classifications
A61M 5/1723 A61M 5/14244 G16H 20/17 G16H 40/67 A61M 2205/18 A61M 2205/3569 A61M 2205/502 A61M 2205/584 A61M 2230/201
Filing Date
2022-09-13
Application No.
19110804
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.